Ironwood Pharmaceuticals | IRWD - 资产



金融业
股票价格
USD
资产
USD 434.57M
现金及等价物
USD 220.47M
销售成本
USD 29.83M
流动资产
USD 332.29M
流动负债
USD 236.31M
债务
USD 583.99M
EBIT
USD 33.22M
EBITDA
USD 81.81M
员工
267
EPS每股收益
USD 0.24
股本和储备
USD -217.14M
销售毛利
USD 85.24M
债务利息支出
USD 8.74M
利息收入
USD 778K
贷款资金
USD 583.99M
市值
USD 613.6M
净收入
USD 3.19M
营业费用
USD 57.33M
营业利润
USD 33.22M
普通股股本
USD 160K
PE价格收益
204.24
税前利润
USD 68.02M
销售收入
USD 106.51M
销售和管理费用
USD 33.33M
贸易债权人
USD 3.24M
应收帐款人
USD 81.89M


资产 更改 日
Acadia Pharmaceuticals USD 1.61B 41.04M 2026-03
Agios Pharmaceuticals USD 1.18B 112.24M 2026-03
Akebia Therapeutics USD 362.52M 14.04M 2026-03
Almirall EUR 2.34B 29.21M 2025-12
Alnylam Pharmaceuticals USD 5.13B 163.22M 2026-03
Amarin USD 645.76M 25.01M 2026-03
Ardelyx USD 504.51M 2.9M 2026-03
Astellas Pharma JPY 3.57T 36.87B 2026-03
AstraZeneca USD 114.02B 59M 2026-03
Charles River Laboratories USD 7.73B 594.89M 2026-03
Coherus Biosciences USD 258.34M 258.18M 2025-12
Emergent BioSolutions USD 1.82B 69.9M 2023-12
Esperion Therapeutics USD 462.53M 3.36M 2026-03
Halozyme Therapeutics USD 2.67B 147.4M 2026-03
Incyte USD 7.34B 381.14M 2026-03
Ironwood Pharmaceuticals USD 434.57M 37.66M 2026-03
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12
Lexicon Pharmaceuticals USD 268.82M 83.83M 2026-03
MacroGenics USD 217.87M 38.97M 2026-03
Moderna USD 11.49B 850M 2026-03
Myriad Genetics USD 673.7M 32.9M 2026-03
Pacira USD 1.21B 56.38M 2026-03
PTC Therapeutics USD 2.87B 29.66M 2026-03
Puma Biotechnology USD 202.86M 7.95M 2025-09
Sarepta Therapeutics USD 3.18B 170.77M 2026-03
Takeda JPY 15.45T 44.34B 2026-03
Ultragenyx Pharmaceutical USD 1.3B 236M 2026-03
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12